EP01.03-004 Should We Screen for Lung Cancer? A 10-Country Analysis Identifying Key Decision-Making Factors

Abstract

Early detection, including early diagnosis and screening, is critical for improving the prognosis of lung cancer. Supported by extensive clinical evidence including NLST and NELSON trials, screening using low-dose computed tomography (LDCT) can effectively reduce lung cancer mortality. However, implementation of formal lung cancer programmes remains limited across the world. This study investigates how governments make decisions on the implementation of formal lung cancer screening programmes and identifies key factors that impact the decision.